Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Impact of angiotensin II type 1 receptor gene polymorphism on insulin resistance in polycystic ovary syndrome.

El-Mesallamy H, El-Refaie T, El-Razek RA.

Exp Clin Endocrinol Diabetes. 2013 Apr;121(4):188-93. doi: 10.1055/s-0032-1333234. Epub 2013 Apr 5.

PMID:
23564192
2.

Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome.

Koika V, Georgopoulos NA, Piouka A, Roupas ND, Karela A, Armeni AK, Katsantoni E, Panidis D.

Eur J Endocrinol. 2012 Apr;166(4):695-702. doi: 10.1530/EJE-11-0894. Epub 2012 Jan 5.

PMID:
22223701
3.

Polymorphism of glycogen synthetase gene in polycystic ovary syndrome.

Rajkhowa M, Talbot JA, Jones PW, Clayton RN.

Clin Endocrinol (Oxf). 1996 Jan;44(1):85-90.

PMID:
8706299
4.

Angiotensin converting enzyme gene insertion/deletion polymorphism in patients with polycystic ovary syndrome.

Karabulut A, Turgut S, Turgut G.

Gynecol Endocrinol. 2010 Jun;26(6):393-8. doi: 10.3109/09513591003632167.

PMID:
20170341
5.

Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women.

Skrgatić L, Baldani DP, Gersak K, Cerne JZ, Ferk P, Corić M.

Coll Antropol. 2013 Mar;37(1):141-6.

PMID:
23697264
6.

Association of glucocorticoid receptor polymorphisms with clinical and metabolic profiles in polycystic ovary syndrome.

Maciel GA, Moreira RP, Bugano DD, Hayashida SA, Marcondes JA, Gomes LG, Mendonça BB, Bachega TA, Baracat EC.

Clinics (Sao Paulo). 2014 Mar;69(3):179-84. doi: 10.6061/clinics/2014(03)06.

7.

Angiotensin-converting enzyme gene polymorphism and risk of insulin resistance in PCOS.

Celik O, Yesilada E, Hascalik S, Celik N, Sahin I, Keskin L, Ozerol E.

Reprod Biomed Online. 2010 Apr;20(4):492-8. doi: 10.1016/j.rbmo.2009.12.014. Epub 2009 Dec 14.

PMID:
20138007
8.

Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.

Yilmaz M, Ergün MA, Karakoç A, Yurtçu E, Yetkin I, Ayvaz G, Cakir N, Arslan M.

Gynecol Endocrinol. 2005 Oct;21(4):206-10.

PMID:
16316841
9.

Association of single nucleotide polymorphisms in adiponectin and its receptor genes with polycystic ovary syndrome.

Yoshihara K, Yahata T, Kashima K, Mikami T, Tanaka K.

J Reprod Med. 2009 Nov-Dec;54(11-12):669-74.

PMID:
20120899
10.

[Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome].

Chen ZJ, Shi YH, Zhao YR, Li Y, Tang R, Zhao LX, Chang ZH.

Zhonghua Fu Chan Ke Za Zhi. 2004 Sep;39(9):582-5. Chinese.

PMID:
15498182
11.

No association of the G972S polymorphism of the insulin receptor substrate-1 gene with polycystic ovary syndrome in lean PCOS women with biochemical hyperandrogenemia.

Marioli DJ, Koika V, Adonakis GL, Saltamavros AD, Karela A, Armeni AK, Tsapanos VS, Decavalas GO, Georgopoulos NA.

Arch Gynecol Obstet. 2010 Jun;281(6):1045-9. doi: 10.1007/s00404-009-1299-2. Epub 2009 Dec 11.

PMID:
20012307
12.

Association of IL-18 genotype with impaired glucose regulation in Korean women with polycystic ovary syndrome.

Kim JW, Lee MH, Park JE, Yoon TK, Lee WS, Shim SH.

Eur J Obstet Gynecol Reprod Biol. 2012 Mar;161(1):51-5. doi: 10.1016/j.ejogrb.2011.12.008. Epub 2012 Jan 5.

PMID:
22226490
13.

[Correlation between interleukin-1 and the obesity of polycystic ovary syndrome].

Yang Y, Qiao J, Li MZ.

Zhonghua Fu Chan Ke Za Zhi. 2012 Jan;47(1):9-13. Chinese.

PMID:
22455686
14.
15.

[Relationship between single nucleotide polymorphism-56 of calpain-10 gene and glucose and lipid metabolism in polycystic ovary syndrome patients].

Diao XH, Shi YH, Gao Q, Wang LC, Tang R, Chen ZJ.

Zhonghua Fu Chan Ke Za Zhi. 2008 Feb;43(2):106-9. Chinese.

PMID:
18683748
16.

Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome.

Yilmaz M, Ergün MA, Karakoç A, Yurtçu E, Cakir N, Arslan M.

Gynecol Endocrinol. 2006 Jun;22(6):336-42.

PMID:
16785159
17.

Vascular endothelial growth factor +405 G/C,-460 T/C and -2578 A/C polymorphisms are not associated with insulin resistance in polycystic ovary syndrome.

Vural P, Küskü-Kiraz Z, Doğru-Abbasoğlu S, Cil E, Karadağ B, Uysal M.

Int J Immunogenet. 2010 Aug;37(4):239-43. doi: 10.1111/j.1744-313X.2010.00915.x. Epub 2010 Apr 30.

PMID:
20477880
18.

Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of Delta4-androstenedione.

Panidis D, Kourtis A, Kukuvitis A, Farmakiotis D, Xita N, Georgiou I, Tsatsoulis A.

Hum Reprod. 2004 Aug;19(8):1728-33. Epub 2004 Jun 3.

PMID:
15178661
19.

Genetic determinants of insulin action in polycystic ovary syndrome.

Haap M, Machicao F, Stefan N, Thamer C, Tschritter O, Schnuck F, Wallwiener D, Stumvoll M, Häring HU, Fritsche A.

Exp Clin Endocrinol Diabetes. 2005 May;113(5):275-81.

PMID:
15926113
20.

The prevalence of Gly972Arg and C825T polymorphisms in Slovak women with polycystic ovary syndrome and their relation to the metabolic syndrome.

Dravecká I, Lazúrová I, Habalová V.

Gynecol Endocrinol. 2010 May;26(5):356-60. doi: 10.3109/09513590903511497.

PMID:
20170352

Supplemental Content

Support Center